Use of GLP-1 receptor agonists and risks of suicide attempts or self-harm in patients with type 2 diabetes: a multicountry self-control case series study
- Zi-Yang Peng
- , Vincent Ka Chun Yan
- , Vincent Kai Chung Wong
- , Ian Chi Kei Wong
- , Esther Wai Yin Chan
- , Eric Yuk Fai Wan*
- , Huang-Tz Ou*
*Corresponding author for this work
- Department of Pharmacy, Queen Mary Hospital, Hong Kong SAR, China.
- The University of Hong Kong, Shenzhen Institute of Research and Innovation, Shenzhen, China.
- Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Research output: Contribution to journal › Article › peer-review
3
Link opens in a new tab
Citations
(SciVal)
2
Downloads
(Pure)